{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:20:08Z","timestamp":1787664008265,"version":"build-2736575974"},"reference-count":92,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["accp1.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Physiologically based pharmacokinetic (PBPK) modeling has emerged as a critical tool for predicting fetal drug exposure during pregnancy, accounting for the complex interplay of maternal physiological changes and placental transfer mechanisms. This review summarizes the current state of PBPK modeling in maternal\u2010fetal pharmacology, discussing various modeling approaches, including compartmental structures and mathematical formulations for placental transfer, as well as approaches to parameterize placental drug transfer in humans. Furthermore, a regulatory perspective on the use of maternal\u2010fetal PBPK models in submissions to the MHRA is provided. Despite advancements, significant gaps remain in understanding the variability of placental drug transfer across gestational stages and the implications of transporter activity. Future research should focus on generating robust clinical data and integrating innovative technologies, such as organ\u2010on\u2010a\u2010chip systems, to enhance model accuracy. Additionally, regulatory acceptance of PBPK models will depend on the establishment of comprehensive validation frameworks. By fostering collaboration between researchers, clinicians, and regulatory bodies, PBPK modeling can advance toward safer therapeutic options for pregnant women and their developing fetuses, ultimately improving maternal\u2010fetal health outcomes.<\/jats:p>","DOI":"10.1002\/jcph.70271","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:15:08Z","timestamp":1787224508000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PBPK Models for Fetal Drug Exposure: A Critical Assessment of Current Approaches and Regulatory Readiness"],"prefix":"10.1002","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1108-5719","authenticated-orcid":false,"given":"Andr\u00e9","family":"Dallmann","sequence":"first","affiliation":[{"name":"Bayer HealthCare SAS  Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4362-940X","authenticated-orcid":false,"given":"Andrew","family":"Butler","sequence":"additional","affiliation":[{"name":"Medicines and Healthcare products Regulatory Agency (MHRA)  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2280-4208","authenticated-orcid":false,"given":"Sophie","family":"Fischer\u2010Holzhausen","sequence":"additional","affiliation":[{"name":"ESQlabs GmbH  Saterland Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4368-8565","authenticated-orcid":false,"given":"Essam","family":"Kerwash","sequence":"additional","affiliation":[{"name":"Medicines and Healthcare products Regulatory Agency (MHRA)  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4452-5867","authenticated-orcid":false,"given":"Julia","family":"Macente","sequence":"additional","affiliation":[{"name":"Drug Delivery and Disposition Unit Department of Pharmaceutical and Pharmacological Sciences KU Leuven  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Nauwelaerts","sequence":"additional","affiliation":[{"name":"ESQlabs GmbH  Saterland Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia M.","family":"Illamola","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology College of Pharmacy University of Minnesota  Minneapolis MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7020-1970","authenticated-orcid":false,"given":"Karen","family":"Rowland Yeo","sequence":"additional","affiliation":[{"name":"Certara UK Ltd (CPT Division)  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9839-2433","authenticated-orcid":false,"given":"Jane","family":"Kn\u00f6chel","sequence":"additional","affiliation":[{"name":"Department of Drug Design and Pharmacology University of Copenhagen  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/CPT.382"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/S10928\u2010020\u201009677\u20101"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/S11095\u2010018\u20102352\u20102\/TABLES\/5"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/CLPT.1985.114"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/JCPH.632"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002\u20109378(95)90107\u20108"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088\u2010200443080\u201000001"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1113\/JP289604"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/FPED.2021.733823\/TEXT"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.121.000538"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12674"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.723006"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS15102455"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.117.075192"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/JCPH.2117"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/PSP4.70136"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/S40262\u2010017\u20100538\u20100\/FIGURES\/1"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.2165\/11597440\u2010000000000\u201000000"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1208\/S12248\u2010022\u201000722\u20100"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.XPHS.2025.103904\/ATTACHMENT\/C2D6DAA3\u20101785\u20104D5D\u20108D25\u201075865ABCE380\/MMC1.DOCX"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/CPT.3656"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.733520"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12815"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/CPT.1748"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/S40262\u2010021\u201001103\u20100\/TABLES\/6"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJOG.2024.05.012\/ATTACHMENT\/8A2B993B\u20101795\u2010431C\u20108757\u2010D2F40B43CDFE\/MMC3.PDF"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1124\/DMD.116.073957\/ASSET\/A27BEC94\u20100891\u20104E05\u20109D86\u20101202E8B72BC5\/MAIN.ASSETS\/FX6.SML"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/CPT.3157"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1124\/DMD.121.000711\/ASSET\/B666AB8B\u20103A34\u20104A16\u2010ACF0\u20103DF5C88BDC8C\/MAIN.ASSETS\/FX5.SML"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJPS.2024.106707"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS16030375\/S1"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2025.1528748\/TEXT"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/PSP4.12899"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262\u2010016\u20100457\u20105"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/S40262\u2010025\u201001574\u20105\/TABLES\/3"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2021.2005565"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2025.1694886\/XML"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498250802050880"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2025.1694886"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2404"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/JCPH.1491"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.120.000067"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/10629360601053893"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/ADHM.201700786"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/FRLCT.2024.1449303"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.3389\/FBIOE.2022.900481\/TEXT"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1039\/D6LC00008H"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262\u2010020\u201000861\u20107"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS16040474\/S1"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.TIV.2022.105471"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262\u2010017\u20100583\u20108"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.734122"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/S40262\u2010022\u201001127\u20100\/FIGURES\/5"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.105068"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.121.000733"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/CPT.3705"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/PSP4.70007"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS16010096\/S1"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2023.1241815\/TEXT"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/BCP.15826"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2023.1068153\/TEXT"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1208\/S12248\u2010025\u201001031\u2010Y\/TABLES\/4"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.840710"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/S11095\u2010024\u201003705\u20102\/FIGURES\/5"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920007782109733"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/CPT.3289"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.PLACENTA.2022.05.003"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.3389\/FCHEM.2021.714678\/TEXT"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41370\u2010022\u201000481\u20102"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JRI.2015.03.001"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.PLACENTA.2021.09.011"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.1113\/JP289607"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.1109\/ACCESS.2023.3272987"},{"key":"e_1_2_10_75_1","unstructured":"European Medicines Agency.Tasigna (Nilotinib): Assessment report.2017.https:\/\/www.ema.europa.eu\/en\/documents\/variation\u2010report\/tasigna\u2010h\u2010c\u2010798\u2010x\u20100088\u2010g\u2010epar\u2010assessment\u2010report\u2010variation_en.pdf."},{"key":"e_1_2_10_76_1","unstructured":"European Medicines Agency.Xarelto (Rivaroxaban): Assessment report for paediatric studies submitted according to Article 46 of Regulation (EC) No 1901\/2006.2018.https:\/\/www.ema.europa.eu\/en\/documents\/variation\u2010report\/xarelto\u2010h\u2010c\u2010000944\u2010p46\u2010042\u2010epar\u2010assessment\u2010report_en.pdf"},{"key":"e_1_2_10_77_1","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.ICH Harmonised Guideline E11A: Paediatric extrapolation.2024.https:\/\/database.ich.org\/sites\/default\/files\/ICH_E11A_Guideline_Step4_2024_0821.pdf."},{"key":"e_1_2_10_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/PSP4.13251"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/PSP4.70097"},{"key":"e_1_2_10_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJPS.2025.107003"},{"key":"e_1_2_10_81_1","doi-asserted-by":"publisher","DOI":"10.1208\/S12248\u2010025\u201001025\u2010W\/FIGURES\/7"},{"key":"e_1_2_10_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/JCPH.2496"},{"key":"e_1_2_10_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/PSP4.13268"},{"key":"e_1_2_10_84_1","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS16091163\/S1"},{"key":"e_1_2_10_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/JCPH.2110"},{"key":"e_1_2_10_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/JCPH.2266"},{"key":"e_1_2_10_87_1","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.General principles for model\u2010informed drug development (M15).2026.https:\/\/database.ich.org\/sites\/default\/files\/ICH_M15_Step4_Final_Guideline_2026_0129.pdf."},{"key":"e_1_2_10_88_1","unstructured":"European Medicines Agency.Guideline on the reporting of physiologically based pharmacokinetic (PBPK) modelling and simulation.2018.https:\/\/www.ema.europa.eu\/en\/documents\/scientific\u2010guideline\/guideline\u2010reporting\u2010physiologically\u2010based\u2010pharmacokinetic\u2010pbpk\u2010modelling\u2010and\u2010simulation_en.pdf."},{"key":"e_1_2_10_89_1","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.E21: Inclusion of pregnant and breast\u2010feeding individuals in clinical trials.2025. Draft version.https:\/\/www.ema.europa.eu\/en\/documents\/other\/ich\u2010e21\u2010guideline\u2010inclusion\u2010pregnant\u2010breastfeeding\u2010individuals\u2010clinical\u2010trials_en.pdf."},{"key":"e_1_2_10_90_1","doi-asserted-by":"publisher","DOI":"10.3389\/FPED.2021.687978\/TEXT"},{"key":"e_1_2_10_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/PSP4.13214"},{"key":"e_1_2_10_92_1","doi-asserted-by":"publisher","DOI":"10.3389\/FPED.2021.698611"},{"key":"e_1_2_10_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/PSP4.13218"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.70271","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jcph.70271","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.70271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:33:44Z","timestamp":1787661224000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/jcph.70271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":92,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1002\/jcph.70271"],"URL":"https:\/\/doi.org\/10.1002\/jcph.70271","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"2026-06-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70271"}}